Navigation Links
ViroPharma Announces Approval of Modernized Labeling for Vancocin® (vancomycin hydrochloride, USP) Capsules
Date:12/14/2011

oducts.aspx">http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

ViroPharma Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including our belief that Vancocin meets the requirements for, and thus received, three years of exclusivity and that the protected labeling cannot be omitted by a generic manufacturer prior to the expiration of the three year exclusivity period. There can be no assurance that: the FDA will confirm our belief that Vancocin meets the requirements for, and thus has received, three years of exclusivity, through listing an exclusivity code in the Approved Drug Products with Therapeutic Equivalence Evaluations (The Orange Book), that even if FDA agrees that the label changes contained in our approved sNDA warrant exclusivity that the FDA would agree that omission of the protected labeling would render generic versions of Vancocin less safe and effective, the FDA will agree with the positions stated in ViroPharma's Vancocin-related submissions or that ViroPharma's efforts to oppose the FDA's bioequivalence recommendation for Vancocin through in vitro dissolution testing will be successful or that the courts reviewing the pending Vancocin related litigation will agree with our positions. In the event that the FDA does not grant three years of exclusivity i
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... July 2, 2015 Roche,s Bloodhound technology ... market segment in hematology testing, according to Kalorama ... recent unveiling of its Bloodhound digital cell imaging ... m 511 hematology analyzer – is notable ... enjoyed by current leader CellaVision, but also compete ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
(Date:7/2/2015)... July 2, 2015   EVO Aesthetic Center and ... provider for non-invasive aesthetics in Lakeway, Texas ... treatments with the Astanza Duality laser. The medical spa ... through various medical and laser procedures. Their addition of ... a clear solution to their tattoo regret. ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... BiPar Sciences, Inc., a,privately held biopharmaceutical ... demonstrating that BSI-401 inhibited pancreatic cancer,cell growth ... and in combination with,oxaliplatin. BSI-401 is BiPar,s ... therapies known as PARP (poly-ADP-ribose polymerase) inhibitors. ...
... share updates about sleep apnea and sleep behavior,disorders, ... offered updates about diagnosing and treating patients with ... and sleep,behavior disorders, at CHEST 2007, the annual ... Chicago on Oct. 20-25. The following are,brief summaries ...
Cached Medicine Technology:BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor 2Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 2Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 3Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 4
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
(Date:7/3/2015)... ... , ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... Deer community with free fitness training and indoor fitness boot camp classes for 24 ... raised thousands of charity dollars and ended with a $10,000 donation to the Jumpstart ...
(Date:7/2/2015)... ... 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... located in Mississippi. The premium frozen yogurt chain was listed as #22 on the ... 104 Railroad Avenue, New Albany, MS 38652, will have a grand opening event on ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is ... is now the 19th sweetFrog store located in the Lone Star State. The premium ... growing companies in 2014. , The store, which opened July 1 at Duke’s Travel ...
Breaking Medicine News(10 mins):Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... By Randy Dotinga HealthDay Reporter , ... that they,ve successfully implanted "biosynthetic" corneas in 10 patients, ... those with cornea-related vision problems. "The patients, own ... overall improvement in vision," said study co-author May Griffith. ...
... it has filed an Investigational New Drug (IND) application ... to begin a Phase I safety clinical trial for ... cells. This multicenter Phase I safety trial will enroll ... injury patients, with an American Spinal Injury Association (ASIA) ...
... and emotional problems a year after surgery than before their ... key findings of a research study of more than 400 ... . Researchers from The Netherlands spoke to 216 ... who had undergone planned surgery, ranging from plastic surgery to ...
... new surge of scientific research has uncovered telltale signs ... and spinal taps, many questions remain unanswered about the ... of patient care, according to Dr. Kenneth S. Kosik, ... California and co-director of UCSB,s Neuroscience Research Institute. ...
... Massachusetts Medical School have identified a novel approach ... decrease the recurrence of glioblastoma multiforme, the most ... horrendous tumors, and new therapies are desperately needed," ... of biochemistry and molecular pharmacology at the University ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... in cleaning up a massive oil spill off the northwest ... health problems facing workers involved in the recent Deepwater ... the Aug. 24 online issue of the Annals of ...
Cached Medicine News:Health News:Biosynthetic Corneas Show Promise in Transplants 2Health News:Biosynthetic Corneas Show Promise in Transplants 3Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 2Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 3Health News:Up to 1 in 4 patients report more physical problems a year after surgery than before 2Health News:Are early testing and drug development the most pressing issues in Alzheimer's care? 2Health News:Double-therapy approach effectively inhibited brain cancer recurrence 2Health News:2002 Oil Spill May Shed Light on Health Problems for Deepwater Workers 2Health News:2002 Oil Spill May Shed Light on Health Problems for Deepwater Workers 3
... Marco could offer you a choice of two ... Chart Projector uses a halogen bulb for longer ... use. The Marco Chart Projector offers a lower ... includes a thermistor for extended bulb life. And ...
... Only Marco could offer you a choice ... The EverLight Chart Projector uses a halogen bulb ... under typical use. The Marco Chart Projector offers ... system that includes a thermistor for extended bulb ...
... The Ultra Series features a modernized optical ... which transmits light more efficiently, producing a ... clarity. The breakthrough optical quality of the ... increase in light transmission, a 15% expanded ...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between....
Medicine Products: